Related Experiment Video

Updated: Jul 16, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Targeted therapy for cancer stem cells: the patched pathway and ABC transporters

H Lou1, M Dean

  • 1National Cancer Institute-Frederick, Frederick, MD 21702, USA.

Oncogene
|February 27, 2007
PubMed

Insights

Cancer stem cells, a small tumor cell population, resist traditional therapies due to self-renewal and drug resistance properties. Targeting these cells alongside non-stem cells may improve cancer treatment efficacy.

Area of Science:

  • Oncology
  • Cancer Biology
  • Stem Cell Research

Background:

  • Certain leukemias, brain, and breast cancers feature a small subpopulation of tumor cells with stem cell-like properties.
  • These cancer stem cells (CSCs) possess self-renewal capacity, mirroring normal stem cells.
  • CSCs constitute a minimal fraction of tumor mass, complicating detection and study.

Purpose of the Study:

  • To investigate the characteristics of cancer stem cells.
  • To understand CSC resistance mechanisms to conventional cancer therapies.
  • To explore novel therapeutic strategies targeting CSCs.

Main Methods:

  • Analysis of CSC properties including self-renewal and resistance.
  • Investigation of CSC survival mechanisms against chemotherapy and radiation.
  • Exploration of targeted therapies focusing on specific pathways and transporters.

Main Results:

  • CSCs exhibit resistance to traditional cancer treatments.
  • High expression of ATP-binding cassette (ABC) drug transporters contributes to CSC resistance.
  • CSCs possess quiescent nature, enhanced DNA repair, and reduced apoptosis.

Conclusions:

  • Cancer stem cells present unique challenges in cancer treatment due to inherent resistance.
  • Combined therapeutic approaches targeting both CSCs and non-stem tumor cells are promising.
  • Targeting the Hedgehog/Patched pathway and ABCG2 drug efflux transporter may offer novel treatment avenues.

More Related Videos

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples09:57

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples

Published on: May 10, 2017

Analysis of Side Population in Solid Tumor Cell Lines06:26

Analysis of Side Population in Solid Tumor Cell Lines

Published on: February 23, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...